EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trimethylamine N-Oxide (TMAO) Inducing Endothelial Injury: UPLC-MS/MS-Based Quantification and the Activation of Cathepsin B-Mediated NLRP3 Inflammasome

Dongyu Lei, Wenbo Yu, Yi Liu, Yujie Jiang, Xiaohui Li, Jing Lv, Ying Li iD

Molecules · 2023

DOI: 10.3390/molecules28093817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Dongyu Lei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410078, China. Hauptthemen laut MEDLINE: Inflammasomes, Cardiovascular Diseases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TMAO is a new risk biomarker for cardiovascular disease. With trimethylammonium as its main chemical skeleton, TMAO is structurally similar to many endogenous metabolites, such as acetylcholine, carnitine, phosphorylcholine, etc. The mechanism of TMAO on the pathological process of CVD is still unclear. In this study, the quantitative analysis of plasma TMAO is conducted, and the contribution of Cathepsin B and NLRP3 inflammasome during the process of TMAO-induced endothelial injury was proposed and investigated at animal and cellular levels. Immunofluorescence assay was applied to represent the protein expression of Cathepsin B and NLRP3 inflammasome located at endothelial cells. The results showed that TMAO could disrupt endothelial cells permeability to induce endothelial injury, meanwhile, TMAO could increase NLRP3 inflammasome activation and promote the activity and expression of Cathepsin B in vitro and in vivo, whereas inhibition of NLRP3 inflammasome activation by MCC950 could protect the endothelial cells from TMAO associated endothelial injury via Cathepsin B. The study reveals that TMAO can cause endothelial injury via Cathepsin B-dependent NLRP3 inflammasome, and inhibition of Cathepsin B and NLRP3 inflammasome can reduce the TMAO-induced damage. The results provide new insight into the role of TMAO in CVD, which can be a potential therapeutic target for disease treatment and drug design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammasomesCardiovascular DiseasesAnimalsNLR Family, Pyrin Domain-Containing 3 ProteinEndothelial CellsCells, CulturedCathepsin BChromatography, High Pressure LiquidChromatography, LiquidTandem Mass SpectrometryMethylamines

Stichwörter der Autor:innen

Cathepsin BNLRP3 inflammasomeTrimethylamine-N-OxideUPLC-MS/MSendothelialinjury

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinCathepsin BtrimethyloxamineMethylamines

Autor:innen und Institutionen

  • Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410078, China.
  • Department of Physiology, School of Basic Medicine, Xinjiang Medical University, Urumqi 830017, China.
  • Department of Health Management, The Third Xiangya Hospital, Central South University, Changsha 410013, China.

ORCID-Profile: Ying Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lei, D., Yu, W., Liu, Y., Jiang, Y., Li, X., Lv, J., & Li, Y. (2023). Trimethylamine N-Oxide (TMAO) Inducing Endothelial Injury: UPLC-MS/MS-Based Quantification and the Activation of Cathepsin B-Mediated NLRP3 Inflammasome. Molecules. https://doi.org/10.3390/molecules28093817

Vancouver

Lei D, Yu W, Liu Y, Jiang Y, Li X, Lv J, et al. Trimethylamine N-Oxide (TMAO) Inducing Endothelial Injury: UPLC-MS/MS-Based Quantification and the Activation of Cathepsin B-Mediated NLRP3 Inflammasome. Molecules. 2023. doi:10.3390/molecules28093817

BibTeX
@article{Lei2023,
  author = {Lei, Dongyu and Yu, Wenbo and Liu, Yi and Jiang, Yujie and Li, Xiaohui and Lv, Jing and Li, Ying},
  title = {Trimethylamine N-Oxide (TMAO) Inducing Endothelial Injury: UPLC-MS/MS-Based Quantification and the Activation of Cathepsin B-Mediated NLRP3 Inflammasome},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28093817}
}
Kostenlos starten →